Search results for “MCH receptors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 465 patents, we discovered top 27 key players by total patent application. Boehringer Ingelheim Pharma GmbH, Boehringer Ingelheim International GmbH, Eli Lilly & Co. are dominant in this area. They take 49.03% of the total patent filing.
Boehringer Ingelheim Pharma GmbH
Austria
Patent: 84
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 76
Eli Lilly & Co.
Indiana, United States
Patent: 68
Taisho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 68
Neurogen Corp.
Connecticut, United States
Patent: 49
Arena Pharmaceuticals, Inc.
California, United States
Patent: 46
7TM A/S
Denmark
Patent: 18
Merck & Co., Inc.
New Jersey, United States
Patent: 17
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 15
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 14
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 3 universities and scientific research institutions by total patent application.
University of Strasbourg
France
Patent: 1
Pukyong National University
South Korea
Patent: 1
Universität Ulm
Baden-Württemberg, Germany
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: